News & Insights
Why Sponsors Should Not Overlook IP
Why Sponsors Should Never Overlook IP Clauses in Clinical Trial Agreements When sponsors negotiate Clinical Trial Agreements (CTAs) with hospitals, universities, or research institutions, the immediate focus often falls
Navigating the Future: How AI Is Changing Clinical Trial Agreement Negotiations
As artificial intelligence (AI) continues to reshape the pharmaceutical and clinical research landscapes, one area undergoing rapid transformation is the negotiation of Clinical Trial Agreements (CTAs). From automating routine
What Is a CRADA?
For sponsors and CROs exploring new sites for clinical research, Veterans Affairs (VA) hospitals are often overlooked—but they shouldn’t be. VA sites offer access to well-established infrastructure, highly experienced
Site Payments Frustrations
Ask almost any clinical trial site or sponsor to name a major pain point in study operations, and you’ll likely hear the same answer: site payments. Despite all the
Leveraging Local Expertise
Efficiently negotiating and finalizing Clinical Trial Agreements (CTAs) is a cornerstone of successful clinical trial management in Europe. While the EU Clinical Trials Regulation (CTR) seeks to create a
Improving Clinical Trials Through Better Planning and Communication
Recently, I attended a conference where I had the opportunity to connect with numerous professionals involved in clinical trials, including individuals from pharmaceutical companies, consulting firms, and contract research